Regulation
Abbott secures CE Mark for Cologuard Plus cancer test
Abbott obtained CE Mark approval under the EU's In Vitro Diagnostic Regulation (IVDR) for Cologuard Plus, a colorectal cancer screening test. The regulatory clearance permits the company to market the diagnostic across European Union member states.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network